DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity

Overview of attention for article published in Vaccine, June 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 4 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 36 Mendeley
connotea: 1 Connotea

Summary Patents Research highlights Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Vaccine composition for naive subjects

Grant US-11065325-B2

United States of America

VACCINE COMPOSITION FOR NAIVE SUBJECTS

Application EP-3431101-A1

European Patent Office

VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS

Application WO-2014095944-A1

World Intellectual Property Organisation (WIPO)

VACCINE COMPOSITION FOR NAIVE SUBJECTS

Application WO-2014095943-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.